2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$41.65+$1.11 (+2.73%)
Price as of Oct 02, 2026 6:07 PM EDT- $6.7BMarket Cap
- 29.69%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$41.65+$1.11 (+2.73%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.54 | ||
Change | +$0.02 (+0.05%) | ||
Open | $40.00 | ||
High | $41.41 | ||
Low | $39.99 | ||
Previous Close | $40.52 | ||
Volume | 2,626,368 | ||
30-Day Average Volume | 2,222,486 | ||
1-Week Change | -0.61% | ||
1-Month Change | -14.11% | ||
1-Year Change | 29.69% | ||
3-Year Change | 44.73% | ||
5-Year Change | 31.28% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.4B | ||
Market Cap | $6.7B | ||
Enterprise Value | $7.7B | ||
Period: QTR TTM FY | |||
Revenue | $411.7M | ||
Net Income | $501,000.00 | ||
Free Cash Flow | $137.0M | ||
EBIT | $5.5M | ||
EBITDA | $35.8M | ||
Net Working Capital | $860.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 214 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 49 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue